Biotech

All Articles

Pfizer takes $230M struck after axing stopped working DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failure has actually blown a $230...

AC Immune sees 'site' possible in Alzheimer's medication data

.After greater than 20 years of deal with neurodegenerative diseases, Swiss biotech hvac Invulnerabl...

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class potential

.GSK has actually ditched a stage 2 individual papillomavirus (HPV) vaccination coming from its own ...

OS Therapies refiles $6M IPO to finance HER2 medication, preclinical ADCs

.OS Therapies will definitely detail on the NYSE American stock substitution this morning via a $6.4...

ALX's fizzling CD47 response rate delivers sell spiraling down

.ALX Oncology's phase 2 stomach cancer cells action price has deteriorated. After finding its own CD...

Ionis centers eye health condition from intendeds of Roche-partnered possibility after information let down

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has actually fallen short of desi...

Biogen's CEO stated no high-risk handle 2023. He's ready to be bold

.While Biogen's pharma peers are looking for late-stage assets along with little threat, chief execu...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipeline after it junked its own lea...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back liberties to an early Alzheimer's illness plan to Denali Therapies, going ou...

Takeda touches new head of US oncology service-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings an...